Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-08
2005-11-08
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S342000, C546S270400
Reexamination Certificate
active
06962933
ABSTRACT:
A 1,3-thiazole compound substituted at the 5-position by a pyridyl group optionally having substituent(s) has a superior p38 MAP kinase inhibitory activity and TNF-α production inhibitory activity.
REFERENCES:
patent: 4612321 (1986-09-01), Terao et al.
patent: 61425 (1982-09-01), None
patent: 149884 (1985-07-01), None
patent: 5-70446 (1993-03-01), None
patent: 11-49762 (1999-02-01), None
patent: 2000-302680 (2000-10-01), None
patent: 97/12876 (1997-04-01), None
patent: 99/21555 (1999-05-01), None
patent: 99/21555 (1999-07-01), None
patent: 99/64418 (1999-12-01), None
patent: 00/49015 (2000-08-01), None
Kimura Hiroyuki
Miwatashi Seiji
Naruo Ken-ichi
Ohkawa Shigenori
Desai Rita
Takeda Pharmaceutical Company Limited
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Method for inhibiting p38 MAP kinase or TNF-α... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting p38 MAP kinase or TNF-α..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting p38 MAP kinase or TNF-α... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3453946